Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. (PBH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PBH · as of Jun 8, 2026
Key Statistics
Explore Prestige Consumer Healthcare Inc. Data
pbh stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 17 · Buy rate: 64.7%
The PBH analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $66.00, representing +38.31% upside from the current price of $47.72.
Competitors & Peers
pbh competitorsPBH
ATEC
CON
CPRX
HTFL
ICUIStock Performance
Full HistoryAbout Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both…
what is prestige consumer healthcare inc. · pbh stock overview · prestige consumer healthcare inc. company profile · who is prestige consumer healthcare inc. ceo · pbh NYSE · prestige consumer healthcare inc. headquarters · prestige consumer healthcare inc. business segments
About Stock Overview & Key Data
Prestige Consumer Healthcare Inc. (PBH) is a Healthcare company in the Medical - Distribution industry, listed on NYSE since Feb 10, 2005. As of the latest trading session, PBH stock price is $47.72, with a market capitalization of $2.3B. The stock has returned -44.30% over the past 12 months and -22.65% year-to-date.
According to 17 Wall Street analysts, the consensus rating for Prestige Consumer Healthcare Inc. stock is Buy, with an average 12-month price target of $66.00. In fiscal year 2026, Prestige Consumer Healthcare Inc. reported revenue of $1.1B and net income of $190.3M. For detailed data — including Prestige Consumer Healthcare Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Prestige Consumer Healthcare Inc. (PBH) stock price is $47.72. The stock is traded on NYSE under the ticker symbol PBH. The 52-week range is $42.62 – $87.12.